The RET (rearranged during transfection) proto-oncogene has attracted much interest in DTC because aberrant activation of RET by somatic rearrangements or point mutations is a unique genetic event in DTC, which also plays a significant role in thyroid carcinogenesis[4, 5]. The gene discussed is RET; the disease is thyroiditis.